Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 07, 2019

SELL
$9.05 - $12.22 $106,265 - $143,487
-11,742 Closed
0 $0
Q2 2019

Jul 25, 2019

BUY
$8.75 - $13.03 $102,742 - $152,998
11,742 New
11,742 $126,000
Q1 2019

Apr 15, 2019

SELL
$7.72 - $12.81 $157,210 - $260,862
-20,364 Closed
0 $0
Q4 2018

Feb 12, 2019

BUY
$9.51 - $16.6 $193,661 - $338,042
20,364 New
20,364 $234,000
Q3 2018

Nov 14, 2018

SELL
$13.05 - $19.05 $141,997 - $207,283
-10,881 Closed
0 $0
Q2 2018

Aug 07, 2018

BUY
$13.9 - $19.8 $151,245 - $215,443
10,881 New
10,881 $155,000

Others Institutions Holding SGMO

About SANGAMO THERAPEUTICS, INC


  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $133M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Quantitative Systematic Strategies LLC Portfolio

Follow Quantitative Systematic Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.